Select Medical Holdings Corp.

As of October 17, 2025, Select Medical Holdings Corp. is considered very expensive and overvalued, with a P/E ratio of 8 and underwhelming stock performance, showing a year-to-date return of -28.97% compared to the S&P 500's 13.30%.

As of October 17, 2025, Select Medical Holdings Corp. is considered overvalued due to its low P/E ratio of 8 compared to peers, a high EV to EBITDA ratio of 6.47, and underperformance with a year-to-date return of -28.97% against the S&P 500's 13.30%.

As of October 3, 2025, Select Medical Holdings Corp. has a mildly bearish trend, with mixed technical indicators and a year-to-date return of -30.98%, significantly underperforming the S&P 500's 14.18%.

As of October 3, 2025, Select Medical Holdings Corp. is in a mildly bearish trend, with daily moving averages and weekly KST indicating bearishness, while the stock has underperformed the S&P 500 significantly, returning -31.41% year-to-date compared to the S&P 500's 14.18%.

As of October 3, 2025, Select Medical Holdings Corp. shows a mildly bearish technical trend with mixed signals across indicators, having underperformed the S&P 500 significantly over the year but outperformed it in the last week.

As of August 1, 2025, Select Medical Holdings Corp. has shifted to a bearish trend with weak momentum indicators, underperforming the S&P 500 with a year-to-date return of -33.00% compared to the S&P's 12.22%.

As of July 7, 2025, Select Medical Holdings Corp. is considered very expensive and overvalued, with a P/E ratio of 8, an EV to EBITDA ratio of 6.47, and a year-to-date return of -33.00%, underperforming the S&P 500's 12.22%.

As of February 20, 2025, Select Medical Holdings Corp. is considered overvalued with a valuation grade of very expensive, reflected by its low P/E ratio of 8 compared to peers and a year-to-date return of -21.01%, despite a dividend yield of 2.40%.

As of May 2, 2025, Select Medical Holdings Corp. is in a bearish trend with moderate strength, indicated by bearish MACD, moving averages, and Bollinger Bands, along with significant underperformance compared to the S&P 500.

As of March 2022, the management team of Select Medical Holdings Corp. includes Executive Chairman Robert Ortenzio, Vice Chairman Rocco Ortenzio, and several independent directors with extensive experience, such as Russell Carson and Thomas Scully.

Select Medical Holdings Corporation operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the U.S. It reported net sales of $1.35 billion and a net profit of $74 million as of March 2025, with a market cap of approximately $1.89 billion.

As of Jun 18, Select Medical Holdings Corp. has a market capitalization of $1.89 billion, with net sales of $6.19 billion and a net profit of $234 million over the latest four quarters.